Company: CMND
Filing Date: 2025-12-03
Form Type: 6-K
Source: 0001213900-25-117537
Chunk: 1

Company: Clearmind Medicine Inc.
Filing Date: 2025-12-03
Form: 6-K
Chunk 1
---
 Form 6-K (this
“Report”) shall not constitute an offer to sell or the solicitation to buy, nor shall there be any sale of, any of the securities
described herein in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or jurisdiction.

A copy of the Securities
Purchase Agreement is filed as Exhibit 10.1 to this Report and is incorporated by reference herein. The foregoing summary of such
document is subject to, and qualified in its entirety by reference to, such exhibit.

A
copy of the opinion of Daniel N. Bloch relating to the securities issued in the Offering is attached as Exhibit 5.1 to this Report.

This Report, excluding Exhibit
99.1, is incorporated by reference into the Company’s Registration Statements on Form F-3 (File Nos. 333-275991, 333-270859, 333-273293)
and Form S-8 (File No. 333-283695),
filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.

Forward Looking Statements

This Report of on Form 6-K
contains statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of
1995 and other securities laws. These forward looking statements are based upon the Company’s present intent, beliefs or expectations,
but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons which are beyond
the Company’s control. For example, this Report states that the Offering is expected to close on or about December 4, 2025. In fact,
the closing of the Offering is subject to various conditions and contingencies as are customary in securities purchase agreements in the
United States. If these conditions are not satisfied or the specified contingencies do not occur, this Offering may not close. For this
reason, among others, you should not place undue reliance upon the Company’s forward looking statements. Except as required by law,
the Company undertakes no obligation to revise or update any forward looking statements in order to reflect any event or circumstance
that may arise after the date of this Report on Form 6-K.

<div align='center'>1

EXHIBIT INDEX</div>

| Exhibit No. |     |                                                             |
| 5.1